IL78061A - Pharmaceutical compositions based on simethicone and guar gum for protection of the oesogastroduodenal mucous membrane - Google Patents

Pharmaceutical compositions based on simethicone and guar gum for protection of the oesogastroduodenal mucous membrane

Info

Publication number
IL78061A
IL78061A IL78061A IL7806186A IL78061A IL 78061 A IL78061 A IL 78061A IL 78061 A IL78061 A IL 78061A IL 7806186 A IL7806186 A IL 7806186A IL 78061 A IL78061 A IL 78061A
Authority
IL
Israel
Prior art keywords
oesogastroduodenal
protection
guar gum
mucous membrane
simethicone
Prior art date
Application number
IL78061A
Other languages
English (en)
Other versions
IL78061A0 (en
Original Assignee
Grimberg Georges Serge
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grimberg Georges Serge filed Critical Grimberg Georges Serge
Publication of IL78061A0 publication Critical patent/IL78061A0/xx
Publication of IL78061A publication Critical patent/IL78061A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL78061A 1985-03-06 1986-03-06 Pharmaceutical compositions based on simethicone and guar gum for protection of the oesogastroduodenal mucous membrane IL78061A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8503306A FR2578423B1 (fr) 1985-03-06 1985-03-06 Composition pharmaceutique a base de gomme de guar pour la protection de la muqueuse oeso-gastro-duodenale

Publications (2)

Publication Number Publication Date
IL78061A0 IL78061A0 (en) 1986-07-31
IL78061A true IL78061A (en) 1991-12-12

Family

ID=9316931

Family Applications (1)

Application Number Title Priority Date Filing Date
IL78061A IL78061A (en) 1985-03-06 1986-03-06 Pharmaceutical compositions based on simethicone and guar gum for protection of the oesogastroduodenal mucous membrane

Country Status (8)

Country Link
US (1) US4764374A (de)
EP (1) EP0194202B1 (de)
JP (1) JPH0629190B2 (de)
AT (1) ATE60713T1 (de)
CA (1) CA1254138A (de)
DE (2) DE3677395D1 (de)
FR (1) FR2578423B1 (de)
IL (1) IL78061A (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5173305A (en) * 1985-03-06 1992-12-22 Grimberg Georges Serge Composition for protection of oesogastroduodenal mucous membrane
US4883788A (en) * 1986-06-06 1989-11-28 Hauser-Kuhrts, Inc. Method and composition for reducing serum cholesterol
US4824672A (en) * 1986-06-06 1989-04-25 Hauser-Kuhrts, Inc. Method and composition for reducing serum cholesterol
FR2621820B1 (fr) * 1987-10-16 1993-11-26 Chicouri Marcel Nouvelles compositions laxatives et leur procede d'obtention
US4965252A (en) * 1988-06-28 1990-10-23 Hauser-Kuhrts, Inc. Cholesterol-lowering combination compositions of guar gum and niacin
US5023245A (en) * 1987-11-10 1991-06-11 Hauser-Kuhrts, Inc. Improved niacin formulation
FR2699074B1 (fr) * 1992-12-11 1995-03-03 Georges Grimberg Procédé d'obtention d'un médicament se présentant sous la forme d'un produit comprimé pouvant être avalé, sucé, croqué, délité.
US5935610A (en) * 1993-08-26 1999-08-10 Mclean; Linsey Composition having buffering properties
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
FR2719999B1 (fr) * 1994-05-17 1996-08-02 Georges Serge Grimberg Composition pharmaceutique à base de gomme de guar et d'un antiacide neutralisant, à laquelle peut être ajoutée une série de principes actifs thérapeutiques.
AU725593B2 (en) * 1997-06-19 2000-10-12 Electronics For Imaging, Inc. Method and apparatus for data compression
EP1408772A2 (de) * 2000-11-29 2004-04-21 Douglas G. Mann Verfahren zur stabilisierung von fruchtkonzentratpulvern
MA41620A (fr) 2015-05-14 2018-01-09 Abdi Ibrahim Ilac Sanayi Ve Ticaret A S Composition pharmaceutique comprenant de la siméthicone et de l'otilonium

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3415927A (en) * 1965-06-09 1968-12-10 American Cyanamid Co Heat modified dispersible guar gum
FR7794M (de) * 1968-10-02 1970-03-31
US3591680A (en) * 1969-11-17 1971-07-06 Smith Kline French Lab Concentrated antacid compositions and method of producing antacid activity
FR2073254A2 (en) * 1969-12-04 1971-10-01 Dausse Laboratoire Gum guar stabilised suspensions - of insoluble medicaments for treati gastrointestinal disorders
US3984571A (en) * 1970-03-10 1976-10-05 E. R. Squibb & Sons, Inc. Hydrocolloid containing liquid carrier for a diagnostic or therapeutic agent
CA1076479A (en) * 1976-09-17 1980-04-29 Lewis/Howe Company Concentrated magnesium hydroxide suspensions or emulsions and method for production thereof
CA1139221A (en) * 1978-10-10 1983-01-11 Vijay B. Surpuriya Antacid compositions

Also Published As

Publication number Publication date
FR2578423B1 (fr) 1988-12-30
IL78061A0 (en) 1986-07-31
JPS61275220A (ja) 1986-12-05
JPH0629190B2 (ja) 1994-04-20
CA1254138A (en) 1989-05-16
FR2578423A1 (fr) 1986-09-12
DE194202T1 (de) 1987-03-19
US4764374A (en) 1988-08-16
EP0194202A1 (de) 1986-09-10
EP0194202B1 (de) 1991-02-06
DE3677395D1 (de) 1991-03-14
ATE60713T1 (de) 1991-02-15

Similar Documents

Publication Publication Date Title
IL78061A (en) Pharmaceutical compositions based on simethicone and guar gum for protection of the oesogastroduodenal mucous membrane
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
IE862404L (en) Hydroxamic acid derivatives
AU575637B2 (en) Oral hygiene compositions
MY101791A (en) New benzimidazole derivatives
OA09850A (fr) Conjugués d'interféron et composés les contenant.
FR2586562B1 (fr) Composition pharmaceutique contenant de l'a-methylhistamine
IL84834A0 (en) Pharmaceutical compositions containing certain n-(1-azabicyclo(2.2.2)oct-3-yl)-benzamides and thiobenzamides
ATE187334T1 (de) Pharmazeutische zusammensetzung in form eines gels mit chondroitinsulfat in salzform zur oralen verabreichung
ATE92303T1 (de) Periodontische zusammensetzung und verfahren.
MA22343A1 (fr) Compositions type massepain, contenant du psyllium
AU629445B2 (en) Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
IE831399L (en) Pharmaceutical composition containing meptazinol and¹ibuprofen.
IT1096665B (it) Composizione farmaceutica per la terapia di stati di frigidita' ed impotenza
SE8704240D0 (sv) Analgesic preparations
IT1187743B (it) Composizioni farmaceutiche a base di destrorfano per applicazione instranasale
DK0911038T3 (da) Vandfri sammensætning omfattende lactulose
ES8801267A1 (es) Procedimiento para preparar derivados de isoquinolinona
FR2607005B1 (fr) Compositions pharmaceutiques contenant de l'acide ursodesoxycholique
NZ333150A (en) di-hydrated lysine salt of N,N'-diacetylcystine and medicaments
GB2180746B (en) Compositions for administering biologically active peptides via mucous membranes
EP0252033A3 (en) Utilization of the "gel" pharmaceutical form containing n-(2.6-dichloro-m-tolil)-anthranilic acid (mechlophenamic acid) utilizable in therapy for topical usage
FR2652086B1 (fr) Compose nouveau d'origine vegetale, derive de l'acide cafeique, l'oraposide; composition a usage therapeutique et composition dermato-cosmetique le contenant.
GR77250B (de)
DE3777411D1 (de) Mittel zur verbesserung der perkutanen verabreichung von arzneimitteln.

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed